Buparvaquone
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101641This classification denotes an antiprotozoal agent with the molecular formula C21H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0354RT7LG4, chemically known as 1,4-naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy- but generally known as buparvaquone, which bears US NIH Compound Identifier 71768. European Medicines Agency schedules Buparvaquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05980MIG. The term BUPARVAQUONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BUPARVAQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buparvaquone under HS 29146990 and SITC 51629. As of Q4 2014, BUPARVAQUONE remains the US FDA Preferred Term for this commodity. Buparvaquone bears US NLM identifiers UMLS ID C0054224 and NCI Concept Code C73276. SMILES: OC1=C(CC2CCC(C(C)(C)C)CC2)C(=O)C(=O)C2C1CCCC2.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.